Although experts may disagree on how to classify neurogenic rosacea pain, they advise dermatologists to get more comfortable with appropriate off-label treatments.

To begin with, Sheer said to be honest about the outcome. “Tell the patient ‘Maybe’ and ‘We will try.’ Have a plan A and plan ...

Many trials that measure the efficacy and safety of antidepressants for MDD exclude one third of real-world patients with the ...

A decade-long nationwide US study reveals that cardiac injury diagnoses after emergency pericardiocentesis decrease in ...

SGLT2 inhibitors show significant benefits in older adults with cardiovascular disease, with consistent benefits across ...

What is a microdose? Consumers dabbling in psychedelics have long believed that taking a tenth to a fifth of a recreational ...

The FDA adds a new boxed warning for immune effector cell-associated enterocolitis with Carvykti, but says the overall ...

Phase 3 studies of hormonal and nonhormonal male contraceptives show promising results as researchers move closer to a ...

A moderated debate between John Mandrola and EARLY TAVR investigator David Cohen on the early treatment of patients with ...

Prof David Kerr discusses a recent study investigating tumor mutational burden as a potential contributing factor to ...

The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I ...

The patient has a rash on her cheeks and nose with sparing of the nasolabial folds, in addition to involvement of the dorsal ...